Skip to content

Action of Curcuma Longa and Piperine on the oxidative and inflammatory profile of patients with Inflammatory Bowel Disease: a randomized, double-blind, placebo-controlled study

Effect of supplementation with Curcuma Longa (extract) and Piperine on inflammatory markers, oxidative stress and glycoxidation in patients with Inflammatory Bowel Disease treated at a Teaching Hospital in Alagoa

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-89q4ydz
Enrollment
Unknown
Registered
2023-07-20
Start date
2019-03-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease

Interventions

This is a double-blind randomized clinical trial. The randomization process of the participants took place through the “runif” command of the “R” software (v. 4.1.3, The R Project Team, Vienna, Austri
All participants were instructed to take two capsules (500 mg, daily after lunch, for three months

Sponsors

Universidade Federal de Alagoas
Lead Sponsor
Universidade Federal de Alagoas
Collaborator

Eligibility

Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with IBD (Crohn's Disease, Ulcerative Colitis or Unclassified Colitis) of mild to moderate intensity; age equal to or greater than 18 years and up to 80 years; Patients using conventional drug therapy for IBD (aminosalicylates, immunosuppressants, biological); Function preserved kidney and liver

Exclusion criteria

Exclusion criteria: Pregnancy; Change or withdrawal of dosage/conventional medication for IBD; HIV positive patients and compromised renal and hepatic function; Patients who made inadequate use of supplementation (did not ingest the recommended daily dose)

Design outcomes

Primary

MeasureTime frame
Expected Outcome 1 - It is expected to find improved antioxidant activity (reduction of lipid peroxidation - malonaldehyde levels (MDA) and oxidized glutathione (GSSG) - increased antioxidant activity - superoxide dismutase (SOD), reduced glutathione (GSH), and reduced inflammatory activity (tumor necrosis factor alpha (TNF?) and interleukins (IL));Outcome found 1 - It was noticed that there were no changes in the inflammatory profile (fecal calprotectin, TNFa and IL) after supplementation with curcumin and curcumin+piperine. Regarding oxidative stress, the group supplemented with curcumin+piperine had an increase in SOD activity (p<0.05) compared to the placebo group.

Secondary

MeasureTime frame
Expected outcome 2 - It was expected to find improvement in gastrointestinal complaints, such as nausea, vomiting, diarrhea, constipation, etc.

Countries

Brazil

Contacts

Public ContactFabiana Moura

Universidade Federal de Alagoas

fabianamoura_al@hotmail.com+55 (82) 98887 -1468

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 6, 2026